Abeona Therapeutics Reports on Initial Safety and Biopotency Signals in MPS IIIB Gene Therapy Clinical Trial

World News: . []

NEW YORK and CLEVELAND Feb 07 2018 GLOBE NEWSWIRE -- Abeona Therapeutics Inc NASDAQABEO a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life-threatening rare genetic diseases, to day rep...

More news and information about Abeona Therapeutics Inc.

Published By:

Globe Newswire: 13:45 GMT Wednesday 7th February 2018

Published: .

Search for other references to "abeona" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us